Autologous CAR T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous CAR T Cells, covering 2024-11-08 to 2024-11-08. Get the full timeline:
Most recent: Clinical Trial Update: Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1]